Skip to main content

Capital Analysts, LLC

SEC CIK
0001624758
Latest filing
Aug 5, 2026

AZN holding history

AstraZeneca PLC in every 13F filed by Capital Analysts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overviewAll 13F holders of AZNFull Q2 2026 holdings

Shares (Q2 2026)
962
Value
$181.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AZN by Capital Analysts, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026962$181.0K<0.1%+148+18.2%AddedHolders
Q1 2026814$158.0K<0.1%−62−7.1%ReducedConverted for a 1-for-2 splitHolders
Q4 20251,752$161.0K<0.1%+875+99.8%AddedHolders
Q3 2025877$67.0K<0.1%−6−0.7%ReducedHolders
Q2 2025883$62.0K<0.1%−175−16.5%ReducedHolders
Q1 20251,058$78.0K<0.1%+107+11.3%AddedHolders
Q4 2024951$62.0K<0.1%+21+2.3%AddedHolders
Q3 2024930$73.0K<0.1%+451+94.2%AddedHolders
Q2 2024479$38.0K<0.1%+19+4.1%AddedHolders
Q1 2024460$31.0K<0.1%+84+22.3%AddedHolders
Q4 2023376$25.0K<0.1%00.0%UnchangedHolders
Q3 2023376$25.0K<0.1%+3+0.8%AddedHolders
Q2 2023373$27.0K<0.1%00.0%UnchangedHolders
Q1 2023373$26.0K<0.1%+5+1.4%AddedHolders
Q4 2022368$25.0K<0.1%−101−21.5%ReducedHolders
Q3 2022469$26.0K<0.1%+208+79.7%AddedHolders
Q2 2022261$17.0K<0.1%00.0%UnchangedHolders
Q1 2022261$17.0K<0.1%+4+1.6%AddedHolders
Q4 2021257$15.0K<0.1%00.0%UnchangedHolders
Q3 2021257$15.0K<0.1%−42−14.0%ReducedHolders
Q2 2021299$18.0K<0.1%00.0%UnchangedHolders
Q1 2021299$15.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.